SBIR/STTR Research Award

Nanowarming technology for effective rewarming of vitrified tissues and organs

Award identifier f71094c66522bef3f81e178ce05375b6e60f981201615d98045c61a5b1df7b74Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,000

Program and phase

SBIR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
TISSUE TESTING TECHNOLOGIES LLC
Proposal award date
2014-12-17
Contract end date
2016-09-30
UEI
ZSY2J1RRALT5
Solicitation number
PA14-071
Topic code
NHLBI

Research abstract

DESCRIPTION provided by applicant There are huge markets for research diagnostic and clinical applications of naturally occurring and engineered cells tissues and organs Strategic assessment of the field has identified the need for better preservation methods because freezing methods of cryopreservation have been shown to damage tissues and organs due to ice formation Vitrification sub zero storage below the glass transition temperature in a andquot glassyandquot rather than a crystalline frozen phase is a form of cryopreservation that avoids ice formation It is an important enabling approach for cellular and regenerative medicine offering the ability to store and transport cells tissues and organs for a great variety of biomedical uses Unfortunately practical application of vitrification has been limited to smaller systems such as cells and thin tissues due to diffusive heat and mass transfer and phase change limitations that preclude use in organs and larger tissues To circumvent this problem we propose using radiofrequency excited magnetic nanoparticles around and within biomaterials This approach has the potential to dramatically improve vitrification through faster and more uniform thawing rates thereby reducing or eliminating devitrification and thermal stress associated cracking to improve viability and structural integrity upon rewarming In addition more rapid warming rates will also permit use of lower concentrations of cryoprotectants that will reduce the risks of cytotoxicity Preliminary experiments have demonstrated that this innovative rewarming technique can increase heating rates by at least an order of magnitude over conventional boundary heating and that it does not depend on sample size We propose using animal derived blood vessel tissue models for development of a new approach for rapidly and uniformly heating vitrified biospecimens in two specific aims The magnetic nanoparticles will be surrounding the vessel and within the vessel lumen In Aim the magnetic nanoparticles will be coated with biocompatible mesoporous silica and the effects of coated magnetic nanoparticle concentration and radiofrequency on a thin walled andlt m animal artery model will be assessed In Aim finite element modeling of heat transfer will be performed followed by experimental evaluation of samples from mL total volume containing animal blood vessels varying in wall thickness andlt andgt m in order to determine the impact of variable non uniform magnetic nanoparticle biodistribution In both aims function of cells and tissues will be demonstrated using established viability assays and effective vitrification will be evaluated using computed tomography and cryosubstitution methods to detect ice formation These studies will combine to test the feasibility of our working hypothesis that andquot radiofrequency excited biocompatible magnetic nanoparticles can be utilized to rewarm large volume samples without devitrification associated ice damage or cryoprotectant toxicityandquot Provided that these studies employing vascular tissue models demonstrate feasibility of our technology we will be assessed vitrification and magnetic rewarming of organs in a future Phase II SBIR proposal PUBLIC HEALTH RELEVANCE This proposal focuses on warming technology development for cryopreservation by vitrification of large volume samples This technology is required for viable functional preservation of many tissues and most organs The technology involves the use of magnetic nanoparticles and radiofrequency induced warming of vitrified banked living biological materials This technology could eventually impact hundreds of thousands of patients in North America annually if applied to allograft tissues tissue engineered cellular constructs and organs

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

22 SBIR/STTR records share this UEI (2014–2023). Reported award amounts total $9,665,888. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.